Ref: Zhai,Y. et al. JAC Antimicrob Resist 3 (1) (2021)

REBASE ref # 32696

Complete sequence: 4,880,275 bp

GenBank #: CP054410

REBASE acronym: EhoK13

Org_num: 50536

 

All begin FCG85_

Type I
ORF Gene Most similar Specificity Name
 
2900 topoisomerase II
2910 M M.CbrF418ORF3185P (97% identity) M.EhoK13ORF2910P
2915 S S.EmoW3M11ORF2525P (61% identity) S.EhoK13ORF2910P
2920 R EcaHAEC1ORF2835P (97% identity) EhoK13ORF2910P
2925 503 aa hypothetical protein
Type II
ORF Gene Most similar Specificity Name
 
2935 HNH endonuclease
2940 R Ero309ORF2605P (97% identity) EhoK13ORF2940P
2945 type I addiction module toxin, SymE family
 
10260 72 aa hypothetical protein
10265 M M.Ecl20710ORF22990P (99% identity) M.EhoK13ORF10265P
10270 55 aa hypothetical protein
 
12195 55 aa hypothetical protein
12200 M M.Eho50319ORF19985P (99% identity) M.EhoK13ORF12200P
12205 72 aa hypothetical protein
 
14045 250 aa hypothetical protein
14050 M M.Eho66ORF11955P (100% identity) M.EhoK13ORF14050P
14055 72 aa hypothetical protein
 
14750 drug/metabolite exporter YedA
14755 V V.EspJJBCDcmP (100% identity) V.EhoK13DcmP
14760 M M.EspJJBCDcmP (100% identity) CCWGG M.EhoK13DcmP
14765 phosphohydrolase
 
16960 Pyocin large subunit
16965 M M.Cfr20C16ORF6915P (91% identity) M.EhoK13ORF16965P
16970 64 aa hypothetical protein
 
17030 DUF1382 family protein
17035 M M.EhoPTE2ORF16605P (98% identity) M.EhoK13ORF17035P
17040 tyrosine-type recombinase/integrase
 
18090 70 aa hypothetical protein
18095 M M.EspYSUORF725P (100% identity) M.EhoK13ORF18095P
18100 DUF3850 domain-containing protein
 
22060 ribulose-phosphate 3-epimerase
22065 M M.ExiPC4LDamP (100% identity) GATC M.EhoK13DamP
22070 cell division protein DamX
Type IV
ORF Gene Most similar Specificity Name
 
2990 MFS transporter
2995 R ExiPC4LMcrCP (100% identity) EhoK13McrCP
3000 R EhoEhh5McrBP (100% identity) EhoK13McrBP
3005 alpha/beta hydrolase
Tech Support Feedback NEB Overview Site Map Trademarks Legal and Disclaimers Privacy Cookie Policy Terms of Use
© Copyright 2023 New England Biolabs. All Rights Reserved.